tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Financial Statements

Compare
277 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently $5.62M. The company's EPS TTM is $-1.77; its P/E ratio is -0.03; Revelation Biosciences is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -7.98M$ -8.66M$ -10.86M$ -11.95M$ -3.80M
EBITDA$ -7.95M$ -8.63M$ -10.84M$ -11.93M$ 0.00
Net Income$ -15.04M$ -120.25K$ -10.83M$ -11.99M$ -3.80M
Balance Sheet
Cash & Short-Term Investments$ 6.50M$ 11.99M$ 5.25M$ 1.27M$ 4.49M
Total Assets$ 6.62M$ 12.21M$ 5.50M$ 2.04M$ 4.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 16.75K$ 0.00
Net Debt$ -6.50M$ -11.99M$ -5.25M$ -1.26M$ -4.49M
Total Liabilities$ 1.91M$ 5.56M$ 4.45M$ 2.14M$ 1.21M
Stockholders' Equity$ 4.71M$ 6.65M$ 1.05M$ -99.47K$ 3.41M
Cash Flow
Free Cash Flow$ -18.34M$ -7.29M$ -11.22M$ -11.22M$ -215.07K
Operating Cash Flow$ -18.32M$ -7.29M$ -11.22M$ -11.09M$ -215.07K
Investing Cash Flow$ -19.17K$ 0.00$ 0.00$ -131.96K$ -74.04M
Financing Cash Flow$ 12.85M$ 14.03M$ 15.20M$ 8.00M$ 74.26M
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS